Various studies have been conducted on the treatment and prognosis of colon cancer, including the use of fluorouracil and leucovorin as adjuvant therapy, the role of cytotoxic and memory T cells in predicting outcomes, the validation of the Immunoscore for classification, the impact of PIK3CA mutation and aspirin use on survival, and the significance of microsatellite instability in colon cancer prognosis.